Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Autor: Famke L. Schneiders, Berend J. Slotman, Suresh Senan, A. Bruynzeel, Miguel A. Palacios, John R. van Sörnsen de Koste, Claire C van Vliet

Publikováno v: van Sörnsen de Koste, J R, van Vliet, C C, Schneiders, F L, Bruynzeel, A M E, Slotman, B J, Palacios, M A & Senan, S 2021, ' Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases ', Physics and Imaging in Radiation Oncology, vol. 20, pp. 1-4 . https://doi.org/10.1016/j.phro.2021.09.001, https://doi.org/10.1016/j.phro.2021.09.001
Physics and Imaging in Radiation Oncology, Vol 20, Iss, Pp 1-4 (2021)
Physics and Imaging in Radiation Oncology, 20, 1-4. Elsevier Ireland Ltd
Physics and Imaging in Radiation Oncology

Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five da

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc655a941a7601e4a7d63eaeaf3c091
https://research.vumc.nl/en/publications/4f93e3fc-2433-456f-98ae-76c7650d8acb